Bunge (BG) Stock Forecast, Price Target & Predictions
BG Stock Forecast
Bunge stock forecast is as follows: an average price target of $128.43 (represents a 31.89% upside from BG’s last price of $97.38) and a rating consensus of 'Buy', based on 9 wall street analysts offering a 1-year stock forecast.
BG Price Target
The average price target for Bunge (BG) is $128.43 based on 1-year price targets from 9 Wall Street analysts in the past 3 months, with a price target range of $144.00 to $105.00. This represents a potential 31.89% upside from BG's last price of $97.38.
BG Analyst Ratings
According to 9 Wall Street analysts, Bunge's rating consensus is 'Buy'. The analyst rating breakdown for BG stock is 0 'Strong Buy' (0.00%), 6 'Buy' (66.67%), 3 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Bunge Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Apr 25, 2024 | Wesley Brooks | HSBC | $105.00 | $104.06 | 0.90% | 7.83% |
| Apr 24, 2024 | Thomas Palmer | Coker Palmer | $122.00 | $105.79 | 15.32% | 25.28% |
| Dec 14, 2022 | - | UBS | $133.00 | $94.47 | 40.79% | 36.58% |
| May 02, 2022 | - | Morgan Stanley | $120.00 | $115.75 | 3.67% | 23.23% |
| Apr 28, 2022 | - | Credit Suisse | $140.00 | $116.41 | 20.27% | 43.77% |
| Apr 28, 2022 | - | BMO Capital | $144.00 | $118.96 | 21.05% | 47.87% |
| Apr 25, 2022 | - | Barclays | $135.00 | $115.56 | 16.82% | 38.63% |
The latest Bunge stock forecast, released on Apr 25, 2024 by Wesley Brooks from HSBC, set a price target of $105.00, which represents a 0.90% increase from the stock price at the time of the forecast ($104.06), and a 7.83% increase from BG last price ($97.38).
Bunge Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $113.50 |
| Last Closing Price | $97.38 | $97.38 | $97.38 |
| Upside/Downside | -100.00% | -100.00% | 16.55% |
In the current month, the average price target of Bunge stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Bunge's last price of $97.38. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 01, 2024 | Citigroup | Buy | Neutral | Downgrade |
| Apr 25, 2024 | HSBC | Buy | Hold | Downgrade |
| Apr 24, 2024 | Citigroup | Buy | Buy | Hold |
| Apr 03, 2024 | Citigroup | Buy | Buy | Hold |
| Feb 13, 2024 | Goldman Sachs | Buy | Buy | Hold |
| Feb 09, 2024 | HSBC | - | Buy | Upgrade |
| Jan 23, 2024 | Barclays | Overweight | Overweight | Hold |
| Aug 04, 2023 | Barclays | Overweight | Overweight | Hold |
| Dec 14, 2022 | UBS | - | Buy | Initialise |
| Jun 30, 2022 | Bank of America Securities | - | Buy | Upgrade |
Bunge's last stock rating was published by Citigroup on Aug 01, 2024. The company Downgrade its BG rating from "Buy" to "Neutral".
Bunge Financial Forecast
Bunge Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $15.05B | $15.33B | $16.66B | $16.76B | $17.93B | $15.88B | $16.68B | $14.12B | $15.39B | $12.96B | $12.61B | $10.16B | $9.46B | $9.17B | $10.78B | $10.32B |
| Avg Forecast | $16.78B | $16.66B | $16.55B | $16.43B | $13.81B | $13.18B | $13.88B | $13.23B | $14.32B | $13.57B | $14.30B | $13.96B | $14.96B | $15.33B | $16.35B | $15.32B | $18.13B | $15.95B | $18.54B | $14.63B | $15.32B | $14.08B | $11.56B | $10.28B | $10.92B | $9.78B | $9.70B | $10.19B | $11.51B | $11.31B |
| High Forecast | $17.84B | $17.72B | $17.59B | $17.47B | $14.68B | $14.01B | $14.76B | $14.06B | $15.22B | $14.37B | $15.21B | $14.84B | $15.20B | $17.44B | $17.39B | $16.29B | $19.28B | $16.96B | $18.54B | $15.74B | $16.48B | $15.15B | $12.44B | $11.06B | $11.75B | $10.52B | $10.44B | $10.97B | $12.38B | $12.17B |
| Low Forecast | $15.23B | $15.12B | $15.02B | $14.92B | $12.54B | $11.96B | $12.60B | $12.00B | $13.00B | $12.76B | $12.98B | $12.67B | $14.73B | $13.94B | $14.84B | $13.91B | $16.46B | $14.48B | $18.54B | $14.00B | $14.66B | $13.48B | $11.06B | $9.84B | $10.45B | $9.36B | $9.29B | $9.75B | $11.01B | $10.82B |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 9 | 6 | 4 | 3 | 7 | 5 | 3 | 4 | 8 | 5 | 9 | 6 | 5 | 10 | 8 | 4 | 4 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.92% | 1.00% | 0.92% | 1.05% | 0.97% | 1.09% | 1.09% | 1.00% | 1.33% | 1.26% | 1.15% | 1.04% | 0.98% | 0.90% | 0.94% | 0.91% |
Bunge's average Quarter revenue forecast for Sep 23 based on 9 analysts is $15.33B, with a low forecast of $13.94B, and a high forecast of $17.44B. BG's average Quarter revenue forecast represents a 1.89% increase compared to the company's last Quarter revenue of $15.05B (Jun 23).
Bunge EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 9 | 6 | 4 | 3 | 7 | 5 | 3 | 4 | 8 | 5 | 9 | 6 | 5 | 10 | 8 | 4 | 4 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.13B | $1.01B | $463.00M | $752.00M | $565.00M | $1.00B | $461.00M | $907.00M | $572.00M | $1.20B | $830.00M | $462.00M | $850.00M | $-162.00M | $55.00M | $-1.43B |
| Avg Forecast | $633.44M | $629.05M | $624.70M | $620.40M | $521.43M | $497.53M | $524.02M | $499.28M | $540.56M | $512.30M | $540.01M | $740.01M | $564.84M | $578.87M | $617.30M | $672.74M | $684.60M | $711.04M | $699.99M | $611.58M | $394.50M | $562.08M | $232.02M | $935.41M | $625.52M | $4.30B | $798.48M | $-583.20M | $97.45M | $-1.34B |
| High Forecast | $673.48M | $668.81M | $664.19M | $659.62M | $554.38M | $528.98M | $557.15M | $530.84M | $574.73M | $542.48M | $574.14M | $888.01M | $573.72M | $658.57M | $656.32M | $807.28M | $727.88M | $853.24M | $699.99M | $733.89M | $473.39M | $674.50M | $278.42M | $1.12B | $750.62M | $5.16B | $958.18M | $-466.56M | $116.94M | $-1.07B |
| Low Forecast | $574.96M | $570.97M | $567.03M | $563.12M | $473.29M | $451.60M | $475.64M | $453.18M | $490.66M | $481.72M | $490.16M | $592.01M | $555.97M | $526.38M | $560.31M | $538.19M | $621.40M | $568.83M | $699.99M | $489.26M | $315.60M | $449.67M | $185.61M | $748.33M | $500.42M | $3.44B | $638.79M | $-699.84M | $77.96M | $-1.61B |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.83% | 1.50% | 0.68% | 1.06% | 0.81% | 1.64% | 1.17% | 1.61% | 2.47% | 1.28% | 1.33% | 0.11% | 1.06% | 0.28% | 0.56% | 1.07% |
9 analysts predict BG's average Quarter EBITDA for Sep 23 to be $578.87M, with a high of $658.57M and a low of $526.38M. This is -48.68% lower than Bunge's previous annual EBITDA (Jun 23) of $1.13B.
Bunge Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 9 | 6 | 4 | 3 | 7 | 5 | 3 | 4 | 8 | 5 | 9 | 6 | 5 | 10 | 8 | 4 | 4 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $622.00M | $632.00M | $336.00M | $380.00M | $206.00M | $688.00M | $232.00M | $653.00M | $362.00M | $831.00M | $551.00M | $262.00M | $516.00M | $-184.00M | $-51.00M | $-1.49B |
| Avg Forecast | $356.86M | $355.32M | $353.78M | $352.27M | $388.91M | $336.88M | $314.43M | $359.90M | $353.46M | $307.16M | $261.66M | $504.58M | $402.56M | $357.51M | $384.92M | $458.71M | $460.29M | $511.92M | $464.09M | $417.01M | $197.68M | $404.68M | $146.84M | $646.69M | $415.25M | $2.44B | $484.73M | $-662.40M | $-90.37M | $-1.40B |
| High Forecast | $386.19M | $384.52M | $382.86M | $381.21M | $420.86M | $364.56M | $340.27M | $389.48M | $382.50M | $324.62M | $283.16M | $605.50M | $435.74M | $377.53M | $416.56M | $550.46M | $498.12M | $614.30M | $464.09M | $500.41M | $237.21M | $485.61M | $176.20M | $776.03M | $498.31M | $2.93B | $581.67M | $-529.92M | $-72.29M | $-1.12B |
| Low Forecast | $314.03M | $312.67M | $311.32M | $309.99M | $342.23M | $296.45M | $276.69M | $316.71M | $311.04M | $298.42M | $230.25M | $403.67M | $362.16M | $297.45M | $338.73M | $366.97M | $405.05M | $409.53M | $464.09M | $333.61M | $158.14M | $323.74M | $117.47M | $517.35M | $332.20M | $1.95B | $387.78M | $-794.88M | $-108.44M | $-1.67B |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.62% | 1.38% | 0.73% | 0.74% | 0.44% | 1.65% | 1.17% | 1.61% | 2.47% | 1.28% | 1.33% | 0.11% | 1.06% | 0.28% | 0.56% | 1.07% |
Bunge's average Quarter net income forecast for Sep 23 is $357.51M, with a range of $297.45M to $377.53M. BG's average Quarter net income forecast represents a -42.52% decrease compared to the company's last Quarter net income of $622.00M (Jun 23).
Bunge SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 9 | 6 | 4 | 3 | 7 | 5 | 3 | 4 | 8 | 5 | 9 | 6 | 5 | 10 | 8 | 4 | 4 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $420.00M | $353.00M | $390.00M | $337.00M | $334.00M | $308.00M | $338.00M | $327.00M | $297.00M | $271.00M | $365.00M | $352.00M | $346.00M | $295.00M | $382.00M | $329.00M |
| Avg Forecast | $453.36M | $450.22M | $447.11M | $444.03M | $373.19M | $356.09M | $375.05M | $357.34M | $386.89M | $366.66M | $386.49M | $225.89M | $404.27M | $414.31M | $441.81M | $205.35M | $489.98M | $256.35M | $501.00M | $186.69M | $289.24M | $202.65M | $120.47M | $210.90M | $275.08M | $3.28B | $325.03M | $1.06B | $676.86M | $308.44M |
| High Forecast | $482.02M | $478.68M | $475.37M | $472.10M | $396.78M | $378.60M | $398.76M | $379.93M | $411.35M | $388.26M | $410.93M | $271.07M | $410.62M | $471.35M | $469.74M | $246.43M | $520.95M | $307.62M | $501.00M | $224.02M | $347.09M | $243.18M | $144.56M | $253.07M | $330.09M | $3.93B | $390.04M | $1.27B | $812.23M | $370.13M |
| Low Forecast | $411.51M | $408.66M | $405.83M | $403.04M | $338.74M | $323.22M | $340.43M | $324.35M | $351.17M | $344.78M | $350.81M | $180.71M | $397.92M | $376.74M | $401.02M | $164.28M | $444.75M | $205.08M | $501.00M | $149.35M | $231.39M | $162.12M | $96.38M | $168.72M | $220.06M | $2.62B | $260.02M | $849.60M | $541.49M | $246.75M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.95% | 1.72% | 0.80% | 1.31% | 0.67% | 1.65% | 1.17% | 1.61% | 2.47% | 1.28% | 1.33% | 0.11% | 1.06% | 0.28% | 0.56% | 1.07% |
Bunge's average Quarter SG&A projection for Sep 23 is $414.31M, based on 9 Wall Street analysts, with a range of $376.74M to $471.35M. The forecast indicates a -1.36% fall compared to BG last annual SG&A of $420.00M (Jun 23).
Bunge EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 9 | 6 | 4 | 3 | 7 | 5 | 3 | 4 | 8 | 5 | 9 | 6 | 5 | 10 | 8 | 4 | 4 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $4.13 | $4.21 | $2.24 | $2.52 | $1.36 | $4.83 | $1.64 | $4.59 | $2.49 | $5.86 | $3.93 | $1.90 | $3.62 | $-1.46 | $-0.36 | $-10.57 |
| Avg Forecast | $2.49 | $2.48 | $2.47 | $2.46 | $2.72 | $2.35 | $2.20 | $2.51 | $2.47 | $2.15 | $1.83 | $2.53 | $2.81 | $2.50 | $2.69 | $3.27 | $3.21 | $2.50 | $3.20 | $2.94 | $2.87 | $1.42 | $1.62 | $1.54 | $1.82 | $0.20 | $1.32 | $0.67 | $0.28 | $0.45 |
| High Forecast | $2.70 | $2.69 | $2.67 | $2.66 | $2.94 | $2.55 | $2.38 | $2.72 | $2.67 | $2.27 | $1.98 | $2.74 | $3.04 | $2.64 | $2.91 | $3.54 | $3.48 | $2.71 | $3.20 | $3.23 | $3.16 | $1.56 | $1.78 | $1.70 | $2.00 | $0.22 | $1.45 | $0.74 | $0.30 | $0.49 |
| Low Forecast | $2.19 | $2.18 | $2.17 | $2.16 | $2.39 | $2.07 | $1.93 | $2.21 | $2.17 | $2.08 | $1.61 | $2.23 | $2.53 | $2.08 | $2.37 | $2.88 | $2.83 | $2.20 | $3.20 | $2.78 | $2.71 | $1.34 | $1.53 | $1.46 | $1.72 | $0.19 | $1.25 | $0.63 | $0.26 | $0.43 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.54% | 1.29% | 0.70% | 1.01% | 0.42% | 1.64% | 0.57% | 3.23% | 1.54% | 3.79% | 2.16% | 9.63% | 2.74% | -2.17% | -1.31% | -23.48% |
According to 9 Wall Street analysts, Bunge's projected average Quarter EPS for Sep 23 is $2.50, with a low estimate of $2.08 and a high estimate of $2.64. This represents a -39.54% decrease compared to BG previous annual EPS of $4.13 (Jun 23).
Bunge Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| BG | Bunge | $97.38 | $128.43 | 31.89% | Buy |
| ADM | Archer-Daniels-Midland Company | $60.39 | $70.60 | 16.91% | Hold |
| DOLE | Dole | $16.16 | $16.67 | 3.16% | Buy |
| AGRO | Adecoagro | $11.57 | $11.50 | -0.61% | Buy |
| CALM | Cal-Maine Foods | $69.38 | $65.00 | -6.31% | Buy |
| TSN | Tyson Foods | $61.40 | $54.42 | -11.37% | Hold |
| LMNR | Limoneira Company | $25.96 | $21.00 | -19.11% | Buy |
BG Forecast FAQ
Is Bunge a good buy?
Yes, according to 9 Wall Street analysts, Bunge (BG) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 6 'Buy' recommendations, accounting for 66.67% of BG's total ratings.
What is BG's price target?
Bunge (BG) average price target is $128.43 with a range of $105 to $144, implying a 31.89% from its last price of $97.38. The data is based on 9 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Bunge stock go up soon?
According to Wall Street analysts' prediction for BG stock, the company can go up by 31.89% (from the last price of $97.38 to the average price target of $128.43), up by 47.87% based on the highest stock price target, and up by 7.83% based on the lowest stock price target.
Can Bunge stock reach $150?
BG's average twelve months analyst stock price target of $128.43 does not support the claim that Bunge can reach $150 in the near future.
What are Bunge's analysts' financial forecasts?
Bunge's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $54.1B (high $57.52B, low $49.1B), average EBITDA is $2.04B (high $2.17B, low $1.85B), average net income is $1.4B (high $1.52B, low $1.23B), average SG&A $1.46B (high $1.55B, low $1.33B), and average EPS is $9.78 (high $10.58, low $8.6). BG's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $66.42B (high $70.62B, low $60.29B), average EBITDA is $2.51B (high $2.67B, low $2.28B), average net income is $1.42B (high $1.53B, low $1.25B), average SG&A $1.79B (high $1.91B, low $1.63B), and average EPS is $9.9 (high $10.72, low $8.72).
Did the BG's actual financial results beat the analysts' financial forecasts?
Based on Bunge's last annual report (Dec 2022), the company's revenue was $67.23B, which missed the average analysts forecast of $67.26B by -0.04%. Apple's EBITDA was $2.89B, beating the average prediction of $2.71B by 6.68%. The company's net income was $1.61B, missing the average estimation of $1.85B by -13.13%. Apple's SG&A was $1.37B, missing the average forecast of $1.43B by -4.53%. Lastly, the company's EPS was $10.74, missing the average prediction of $11.86 by -9.45%. In terms of the last quarterly report (Jun 2023), Bunge's revenue was $15.05B, missing the average analysts' forecast of $16.35B by -7.97%. The company's EBITDA was $1.13B, beating the average prediction of $617.3M by 82.73%. Bunge's net income was $622M, beating the average estimation of $384.92M by 61.59%. The company's SG&A was $420M, missing the average forecast of $441.81M by -4.94%. Lastly, the company's EPS was $4.13, beating the average prediction of $2.69 by 53.63%